divalproex sodium ER
Sponsors
University Hospitals Cleveland Medical Center, Tuscaloosa Research & Education Advancement Corporation, Montefiore Medical Center, University of South Florida, Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Conditions
AutismBipolar DepressionBipolar DisorderDrug InteractionEpilepsyGeneralized Anxiety DisorderPanic DisorderSchizophrenia
Phase 1
A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy Men
CompletedNCT01060228
Start: 2009-01-31End: 2009-02-28Updated: 2012-12-24
Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite
CompletedNCT04902105
Start: 2021-05-13End: 2021-07-06Updated: 2021-07-22
Phase 3
Phase 4
Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder
CompletedNCT00203528
Start: 2004-01-31End: 2007-02-28Target: 30Updated: 2007-03-19
Divalproex Sodium ER in Adult Autism
CompletedNCT00211796
Start: 2005-04-30End: 2007-04-30Target: 10Updated: 2018-05-31
Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD
CompletedNCT00579280
Start: 2007-07-31End: 2010-12-31Updated: 2020-06-11